Oxidative metabolism of human platelets.
The reducing capacity toward cytochrome c present in human resting platelets increases upon platelet stimulation, and is partially inhibited by superoxide dismutase. This activity therefore represents the generation of superoxide anion. In order to evaluate hydrogen peroxide formation a quantitative assay by mean of dichlorofluorescin (DCFH) has been set up. The DCFH, trapped inside the cell, is oxidized by hydrogen peroxide to the fluorescent compound DCF. Basal DCF increases during activation of platelets by agonists. Arachidonic acid, calcium ionophore A23187 and to a lesser extent PMA and thrombin are the most effective. N-ethylmaleimide induces a dose-dependent DCFH oxidation and potentiates the effect of agonists. NAD(P)H--cytochrome c reductase enzyme, which catalyzes superoxide anion production, is present in platelets at high specific activity, as well as those enzymes who protect the cells from oxygen reactive species.
Leoncini
G
G
Istituto Policattedra di Chimica Biologica, Università di Genova, Italia.
Maresca
M
M
Colao
C
C
D001792:Blood Platelets / Q000187:drug effects / Q000378:metabolism*; D003574:Cytochrome c Group / Q000097:blood; D005033:Ethylmaleimide / Q000494:pharmacology; D005452:Fluoresceins; D006801:Humans; D006861:Hydrogen Peroxide / Q000097:blood; D066298:In Vitro Techniques; D009247:NADH, NADPH Oxidoreductases / Q000097:blood; D019255:NADPH Oxidases; D010084:Oxidation-Reduction; D015539:Platelet Activation; D013481:Superoxides / Q000097:blood
D003574:Cytochrome c Group; D005452:Fluoresceins; D013481:Superoxides; C037631:2',7'-dichlorofluorescein; D006861:Hydrogen Peroxide; D009247:NADH, NADPH Oxidoreductases; D019255:NADPH Oxidases; D005033:Ethylmaleimide